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Abstract: Thanks to their high biocompatibility and bioactivity, bioactive glasses are very promising
materials for soft and hard tissue repair and engineering. Because bioactivity and specific surface
area intrinsically linked, the last decade has seen a focus on the development of highly porous
and/or nano-sized materials. This review emphasizes the synthesis of bioactive glass nanoparticles
and materials design strategies. The first part comprehensively covers mainly soft chemistry
processes, which aim to obtain dispersible and monodispersed nanoparticles. The second part
discusses the use of bioactive glass nanoparticles for medical applications, highlighting the design of
materials. Mesoporous nanoparticles for drug delivery, injectable systems and scaffolds consisting of
bioactive glass nanoparticles dispersed in a polymer, implant coatings and particle dispersions will
be presented.
Keywords: bioactive glass; nanoparticles; sol-gel; biomedical applications
1. Introduction
Since their discovery in the 1970s by Hench, bioactive glasses have been the subject of intensive
investigations as biomaterials for bone tissue repair and replacement [1]. Their attractiveness lies in
their ability to chemically bond with host tissues that are directly related to their atomic structure.
When a bioactive glass is implanted, it dissolves gradually and the ions released promote the growth
of a carbonated hydroxyapatite layer at its surface. This dissolution mechanism is enhanced by the
low connectivity of the SiO2 network, thanks to the presence of network modifiers, like sodium and
calcium, leading to the formation of non-bridging silicon-oxygens bonds [2]. Briefly, surface Na and Ca
cations are first exchanged with H+ from the biological fluid, creating Si-OH bonds. If present initially,
phosphate ions can also be released. Then, more Si-OH bonds are formed because of the hydrolysis of
Si-O-Si bonds due to a pH increase and they re-polymerize, creating a glass surface depleted in Na
and Ca cations. The migration of Ca2+ and PO43´ ions to the surface follows, inducing the formation
of an amorphous calcium phosphate layer, which then crystallizes into biomimetic hydroxyapatite
thanks to the incorporation of hydroxide and carbonate ions from the biological fluid [3,4].
Because bioactivity is directly related to the glass dissolution rate, it is obvious that it will also be
dependent on its morphology. The higher the specific surface area, i.e., the contact surface between the
material and the physiological fluid, the greater the glass bioactivity. Strategies to obtain a significant
specific surface area imply an increase in the porosity and/or a decrease in the size of the materials
synthesized. With a high surface-to-volume ratio, bioactive glass nanoparticles (20–500 nm) are thus
of tremendous interest not only because they present a larger specific surface area, but also a higher
surface energy compared to micrometric-sized particles [5,6]. In addition, their nanometric size allows
material shaping versatility. The bioactive nanoparticles can be dispersed in a polymer scaffold, used
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to create a bioactive coating on implants, dispersed or even to be directly injected. It is worth noting
that upon decreasing their size, the dispersion of nanoparticles becomes increasingly difficult and can
thus pose a challenge. Finally, it is worth noting that their size also permits them to be internalized by
different type of cells (macrophages, bone cells, cancer cells, etc.). If well controlled and oriented, this
could be very interesting for drug delivery and cancer treatment, for example.
This review will first present the strategies for producing bioactive glass nanoparticles, focusing
mainly on the sol-gel process. In a second part, their fields of applications for hard tissue (bones, teeth)
regeneration and repair, and also for soft tissue regeneration, wound healing and drug delivery will
be described. The focus will always be placed on the design of the bioactive materials, and on their
structure/properties relationships.
2. Synthesis of Bioactive Glass Nanoparticles
2.1. From Melt-Derived Glass to Sol-Gel Chemistry
The original bioactive glass developed by Hench has a composition of 45% SiO2, 24.5% Na2O,
24.5% CaO and 6% P2O5, and has been prepared through a conventional high-temperature melting
process, i.e., through the melting of oxides mixed together at more than 1300 ˝C followed by a
quenching step [7]. Though this process does not permit nanoparticles to be obtained, high-temperature
syntheses do not always result in large-scale objects: flame spray synthesis has been used to produce
bioactive glass nanoparticles [8]. Metal-organic precursors has been mixed and fed into a flame reactor
and the nanoparticles collected on a filter above the flame. This temperature quenching allowed the
formation of 20–80 nm amorphous particles.
In the 1990s, soft chemistry strategies and particularly the sol-gel process emerged, providing a
more versatile method to design bioactive glass nanoparticles. In contrast to the previously described
routes, sol-gel technology allows the synthesis of bioactive glasses of equivalent composition but
at a much lower temperature. This process is based on hydrolysis and condensation of molecular
precursors (alkoxydes or salts), which lead to the formation at room temperature and ambient pressure
of an inorganic polymeric network. Solvent being trapped within the network explains the gel-like
texture. In the case of pure silica, the hydrolysis and poly-condensation of tetraethyl orthosilicate
(TEOS) induces the formation of primary colloidal nanoparticles (sol), which later agglomerate to
form a 3D, highly connected network in acidic conditions or spherical secondary particles in basic
conditions (also known as the Stöber process [9]). Because glasses produced in both acidic and basic
media are made of coalesced nanoparticles, they present a lot of inter-particular interstices [10]. Hence
the glasses synthesized through this process have a higher porosity compared to melt-derived ones.
This conclusion has also been confirmed for SiO2-CaO-(Na2O)-P2O5 bioactive glasses (the role of
Na2O being to reduce the glass fusion temperature, it has not been used for the sol-gel process)
while comparing the specific surface area and the porosity of particles of similar sizes obtained by
a melt-quenching route and a sol-gel route. Sol-gel-derived particles present a pore volume and a
specific surface area two orders of magnitude higher than the melt-derived ones [11]. This makes
them highly attractive in the biomaterial fields since, as said before, bioactivity is linked to the specific
surface area of the materials as it has a direct impact on glass dissolution and apatite formation rates.
In addition, numerous Si-OH bonds are still present once the glass is formed as the low elaboration
temperature does not promote oxolation reactions, resulting in a lower connectivity of sol-gel glasses
compared to melt-quenched ones. It is also worth saying that the sol-gel process is highly versatile as
particles size and morphology can be tuned while playing on the initial water/alcohol ratio, the nature
of the alcohol, the type of precursor, and the concentration and the nature of the catalyst (HNO3, citric
acid, HCl, NH4OH) [12]. In brief, using sol-gel chemistry, bioactivity can thus be controlled not only
by the composition, but also by the process in itself.
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2.2. Looking into the Core of Sol-Gel Strategies
To produce bioactive glass sol-gel nanoparticles, research groups have modified the classical
Stöber process in order to introduce Ca2+ and sometimes PO43´ ions into the silica network. Of course,
it is also possible through a milling step to obtain nanoparticles from a silica monolith (top-down
approach), but the particles are neither homogeneous in size nor in shape [13]. Common precursors
for calcium and phosphorous are respectively calcium nitrate and triethylphosphate (Et3PO4) or
diammonium hydrogen phosphate ((NH4)2HPO4). From reviewing the literature, two trends emerge.
1. The first one involves the synthesis of silica nanoparticles followed by Ca2+ (and PO43´)
adsorption onto their surface [14,15];
2. The second one introduces calcium (and phosphate) ions along with the silica precursor prior to
increase the pH in order to form the particles. In the latter strategy:
(i) TEOS/Ca2+(/PO43´) acidic mixture is sometimes added to an ammoniac solution [15–19];
(ii) and, on the contrary, sometimes concentrated NH4OH is dropped inside the
TEOS/Ca2+(/PO43´) acidic mixture [20–23].
They are schematically represented in Figure 1.
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Figure 1. Schematic representation of the different strategies to synthesize binary bioactive glass 
nanoparticles (SiO2-CaO). 
The particles obtained in the syntheses referenced previously are shown in Figure 2. All these 
processes present common steps. For example, all differ from the original Stöber process because 
they add a hydrolysis step of TEOS in acidic media before accelerating the condensation and induce 
particle formation by the addition of concentrated NH4OH. Adding calcium ions after the formation 
of silica nanoparticles seems to be an efficient way to prevent them to interfere during the 
hydrolysis/condensation process and thus prevent the formation of spherical particles, as reported by 
Lukowiak et al. in comparative syntheses, where only the moment when Ca(NO3)2 salt is added has 
been varied [15]. However, it has also been shown that particles with controlled morphology can be 
obtained even if calcium salt is mixed with TEOS at the beginning of the synthesis (cf. Figure 2) [15,16]. 
Figure 1. Schematic representation of the different strategies to synthesize binary bioactive glass
nanoparticles (SiO2-CaO).
The particles obtained in the syntheses referenced previously are shown in Figure 2. All
these processes present common steps. For example, all differ from the original Stöber process
because they add a hydrolysis step of TEOS in acidic media before accelerating the condensation and
induce particle formation by the addition of concentrated NH4OH. Adding calcium ions after the
formation of silica nanoparticles seems to be an efficient way to prevent them to interfere during the
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hydrolysis/condensation process and thus prevent the formation of spherical particles, as reported by
Lukowiak et al. in comparative syntheses, where only the moment when Ca(NO3)2 salt is added has
been varied [15]. However, it has also been shown that particles with controlled morphology can be
obtained even if calcium salt is mixed with TEOS at the beginning of the synthesis (cf. Figure 2) [15,16].
One can see that it is extremely difficult to understand which are the parameters that have an
actual impact on particles size and morphology, as all the protocols referenced here have different
introduction precursors orders, different stabilization times between the addition of each one, different
water/ethanol ratios and precursor concentrations, different types of acid (HNO3 or citric acid) and
phosphorous precursors (Et3PO4 or (NH4)2HPO4), if there is one. Therefore, systematic studies are
still needed in order to fully understand the role of each of the latter parameters.
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Figure 2. Selection of TEM or SEM images of bioactive glass nanoparticles synthesized by different
groups. Adapted with permission from [14] (a); [16] (c); [17] (g), ©Wiley; [18] (e); [20] (h); [21] (i); [23]
(k), ©Elsevier; [15] (b,d), ©Royal Society of Chemistry; [19] (f) and [22] (j), ©Springer.
Table 1 summarizes experimental conditions for the syntheses mentioned previously. For example,
it has been shown that the Si:Ca ratio value was critical to obtain spherical particles, even when calcium
is added after the formation of SiO2 particles [14]. This result is all the more important given that the
Ca(NO3)2:TEOS optimal ratio was shown to be 0.57:0.43, which is far from the one usually used, and
stoechiometrically identical to the desired particles composition, 0.3:0.7. Additionally, the calcium
amount seems to impact the final size of the particles: as shown by Yun et al. in a synthesis involving
hexadecyl trimethylammonium bromide (CTAB) as the template, increasing calcium nitrate quantity
induced a decrease in diameter, from 160 to 30 nm [24].
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Table 1. Comparison of experimental conditions for different sol-gel syntheses protocols.
Strategy Reference Acid PO4
3´
Precursor
Water:EtOH
Vol. Ratio Si:Ca(:P)
[Tetraethyl Orthosilicate (TEOS)]
(mol/L) Drying Annealing
1
[14] / / 0.11:1 0.43:0.57 0.045 Not detailed 680 ˝C
[15] HNO3 / 0.39:1 0.74:0.26 0.14 80 ˝C 24 h 700 ˝C 2.5 h
2.i
[16] citric acid / 12.7:1 0.70:0.30 0.043 freeze-drying 700 ˝C
[15] citric acid / 13.2:1 0.74:0.26 0.043 80 ˝C 24 h 700 ˝C 2.5 h
[18] HNO3 (NH4)2HPO4 26.7:1 0.58:0.37:0.05 0.031 25 ˝C 24 h 650 ˝C 3 h
[19] citric acid (NH4)2HPO4 27.5:1 0.52:0.38:0.10 0.026 Not detailed 700 ˝C 3 h
[17] citric acid (NH4)2HPO4 8.03:1 0.39:0.35:0.26 Not detailed 60 ˝C 8 h 700 ˝C 6 h
2.ii
[20,21] HNO3 Et3PO4 0.33:1 0.61:0.36:0.03 1 80 ˝C 48 h 700 ˝C 3 h
[22] HNO3 Et3PO4 1.2:1 0.55:0.38:0.07 0.96 130 ˝C 24 h 600 ˝C 4 h
[23] HNO3 Et3PO4 0.33:1 0.57:0.35:0.08 1.1 60 ˝C 24 h 600 ˝C 2 h
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Another common step to all the bioactive glass nanoparticle syntheses referenced above is a
thermal annealing at 600–700 ˝C. This treatment is necessary to eliminate nitrate ions and to allow
the diffusion of calcium ions inside the silica network. 29Si Magic Angle Spining (MAS)-NMR
measurements realized onto bioactive glass before and after such thermal treatment have shown
a decrease in silica network connectivity, hence proving that Ca2+ ions initially adsorbed onto the glass
surface have been incorporated as network modifiers [10]. The necessity of such a high temperature
heat treatment can lead to the agglomeration and coalescence of the as-synthesized particles, an effect
that is all the more important as their size decreases, as their surface energy increases. One solution
could be to use calcium methoxyethoxide as calcium source instead of calcium nitrate, as calcium
would be directly involved in the inorganic polymerization process and thus inserted inside the silica
network. Some groups successfully obtained bioactive glasses with calcium insertion in the network
at low temperature [25,26]. However, to the knowledge of the authors, nanoparticles have not been
yet produced using this alkoxyde precursor. It is important to mention that particle agglomeration is
not only promoted because of the post-synthesis annealing step, but also by the decrease in particles’
surface charge during the synthesis. Pure silica particles have a zero charge pH value of about 2,
meaning that for pH values lower than 2, their surface is positively charged (-OH2+ groups), and
for pH values higher than 2, their surface is negatively charged (-O´ groups). The surface charge is
characterized through the measure of zeta potential. Usually, it is considered that a zeta potential above
|30| mV leads to the colloidal dispersion of particles in a medium. During bioactive glass synthesis,
the pH value is quickly raised to ~11 in order to promote the formation of particles (Stöber process).
Due to the high pH value, particles are electrostatically repulsed from each other and no agglomeration
should occur. However, the addition of Ca2+ ions in the media and their adsorption at the particles
surface decreases their surface charge and thus leads to particles agglomeration. In the literature, zeta
potential values of ´16.2 mV [27], ´10 and ´15 mV [19] at physiological pH have been reported after
annealing. To minimize agglomeration, vigorous stirring is necessary, but most of syntheses still show
a high degree of agglomeration (cf. Figure 2). However, carrying out the sol-gel process, and more
particularly NH4OH addition, under ultrasonic treatment (in addition the mechanical stirring) has
shown to lead to non-agglomerated bioactive glass nanoparticles [14]. Additionally, freeze-drying the
particles prior to their annealing seems to give good chances for obtaining a colloidal suspension [16].
2.3. Of the Use of Additives and Surfactants
Still with the objective of shaping particles and preventing their agglomeration, surfactant and
additives have been used by some groups. For example, Luz and Mano have shown that the addition
of Polyethylene glycol (PEG )chains of different molecular weights at the end of the sol-gel process
induced a change in particles morphology: smaller molecular chains PEG resulted in the formation of
dense particles, whereas larger chains resulted in more agglomerated hollow particles [19]. Boltorn™
(Perstorp, Malmö, Sweden) polymer has also be used as a template by one group in an attempt to
avoid particles agglomeration [28]. More successfully, a long chain amine (dodecylamine)-assisted
sol-gel route has led to 200–300 nm spherical particles with a good dispersibility in water and ethanol
solution [29]. CTAB is another templating agent that has been used to shape particles. It has been
reported that increasing CTAB concentration from 1 to 6 mM changed the shape of the particles from
spherical to rod-like [30]. Another study showed that increasing CTAB concentration from 3.3 to
5.9 mM leads to a decrease in the size of the particles, from 294 to 187 nm, and more importantly to a
change in their structure, as for CTAB concentrations of 3.3 and 4.6 mM the particles were hollow, and
for 5.9 mM they were dense [31]. One can note that CTAB concentration alone is not the only parameter
which defines the morphology of obtained particles. In these two studies, even if the protocols were
highly similar, precursor concentrations and the solvent were different. This again highlights the need
of systematic studies to fully comprehend the role of each parameter on the particles morphology.
Synthetizing bioactive glass nanoparticles in micro-emulsions or nano-reactors is another route
which has been explored in order to minimize their agglomeration. The principle is that a sol-gel-like
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reaction will take place in droplets formed by surfactants. Using poly(styrene-b-acrylic acid) and CTAB,
Li et al. have obtained monodispersed 250 nm hollowed particles [32]. With a similar protocol, but
using ethyl acetate along with CTAB, Liang et al. also obtained mesoporous well-defined particles,
with a size ranging from 133 to 254 nm depending on the ammonia concentration used [33]. Finally,
by a water-in-oil micro-emulsion route using Triton-100 as surfactant, n-hexanol as co-surfactant
and cyclohexane as organic media, Lukowiak et al. synthesized monodispersed hollowed 90 nm
nanoparticles which can be well dispersed in ethanol [15].
3. Materials Design for Biomedical Applications
The first part of this review focused on the preparation of bioactive glass nanoparticles through
soft chemistry processes. But these particles will often not be used as-synthesized for biomedical
applications. The second part will thus deal with the design of materials for biomedical applications,
i.e., the conception and elaboration of materials with specific structures, morphologies, tailored with
the aim to use them for precise clinical purposes.
3.1. Nanoparticles for Drug Delivery and Ionic Therapy
Bioactive glass nanoparticles produced by sol-gel chemistry present high specific surface area and
are biocompatible; they are thus good candidate to be carriers for drug delivery. Although bioactive
sol-gel glasses have an inherent mesoporosity, it is possible, by combining sol-gel and surfactant
supramolecular chemistries, to obtain ordered mesopore structures, presenting even a higher specific
surface area [34]. When mixed inside the sol with an appropriate concentration, surfactants like
CTAB, or pluronics F127® or P123® (BASF, Florham Park, NJ, USA) will self-organize into micelles.
Along with the gelation process, the micelles will auto-assemble (evaporation-induced self-assembly),
and after a thermal treatment, bioactive glasses with well-ordered mesopores will be obtained. Pore
organization and sizes thus depend on both the surfactant used and its concentration [34,35], and due to
its interaction with Ca2+ ions, to the composition of the bioactive glass [36]. To higlight the dependence
of pore size, pores arrangement, particle morphology and thus the specific surface area of mesoporous
bioactive glasses on the glass composition and on the surfactant nature and concentration, all these
characteristics have been listed in Table 2 for a selection of studies. Adding 1–6 mM of CTAB to the
sol-gel synthesis, spherical or elongated particles of sizes ranging from 30 to 300 nm were successfully
synthesized [24,30,31]. It has been shown that the particles size was dependent on surfactant [30,31]
and calcium [24] concentrations. With the addition of ethyl acetate along with CTAB, Liang et al.
have obtained spherical particles with radial mesostructure, with a size ranging from 130 to 250 nm,
depending on ammoniac concentration [33]. More interestingly, they showed that a solvothermal
treatment induced the formation of pineal nanoparticles with a lamellar mesostructure, particles with
an aspect ratio depending on the ammoniac concentration [33]. Hollow 250 nm particles with 20 nm
pores inside the core and a vertical mesostructured 50 nm-thick shell have been synthesized using a
dual soft template route using poly(styrene-b-acrylic acid) and CTAB [32]. This study distinguishes
itself from the previously cited ones on the analysis of a cancer drug (doxorubicin) load and release.
The particles present a remarkably high drug loading capacity (830 mg/g) and undergo a two-stage
release linked to the particles peculiar morphology. It has been explained by a fast release of drug
loaded in the mesoporous shell and a slower release due to the diffusion of drug molecules from the
hollow core to the shell and then to the solution.
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Table 2. Morphology, composition, specific surface area, pore size and arrangement of mesoporous bioactive glasses from the literature, along with the surfactant used
for their synthesis.
Reference Morphology Size CompositionSi:Ca(:P) Surfactant
Specific Surface
Area (m2/g) Pore Size (nm)
Pore
Arrangement
[37] Microsphere 1 mm 0.80:0.15:0.05 P123 9.2 mM 336 5 Hexagonal
[38] Monoliths /
0.95:0.05
P123 9.2 mM
338 5.5
Hexagonal0.84:0.16 229 5.2
0.73:0.27 147 5.2
0.63:0.37 159 4.6
[32]
Hollow
nanoparticles
250 nm
250 nm 0.80:0.15:0.05
Hexadecyl
trimethylammonium
bromide (CTAB)
6.9 mM
949 2.6
Vertical
mesochanels in
the shell
[36]
Polydispersed
nanoparticles
Mean size of
400 nm
0.82:0.09:0.09
CTAB 28.1 mM 484 1.1 + 3.7
Defective orderP123 1.8 mM 380 3.9
F127 0.8 mM 275 3.5 Hexagonal
[31]
Hollow
nanoparticles 294 nm
0.77:0.15:0.08
CTAB 3.3 mM 444 8.8 Not detailed
Hollow
nanoparticles 264 nm CTAB 4.6 mM 600 5.6 Not detailed
Dense nanoparticles 187 nm CTAB 5.9 mM 972 4.6 Not detailed
[30]
Nanoparticles 150 nm
0.77:0.15:0.08
CTAB 1 mM 318 3.7 Worm-like
Nanorods 150 ˆ 380 nm CTAB 3 mM 388 3.7 Worm-like
Nanorods 150 ˆ 550 nm CTAB 6 mM 455 3.7 Hexagonal
[24] Nanoparticles 30 nm 0.79:0.17:0.04 CTAB 1.7 mM 1040 2.2 Worm-like
[33]
Nanoparticles 133 nm
0.58:0.35:0.08 CTAB 35.6 mM
684 5.1
Radial
mesostructure
Nanoparticles 234 nm 349 7.8
Nanoparticles 254 nm 259 11.2
Pineal particles 28 nm 151 9.9
Lamellar
mesostructure
Pineal particles 161 nm 280 10.5
Pineal particles 193 nm 192 14.0
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It is also interesting to note that drug loading and release kinetics can be controlled by bioactive
glass calcium content [38]. Increasing the CaO quantity from 0% to 25% induced an increase in
tetracycline (antibiotic) loading capacity from 105 to 174 mg/g and a decrease in drug release content
from 95% to 25% after 120 h soaking in simulated body fluid. These results have been explained by
the chelation of the drug to calcium species in the pore walls. The slow drug release of bioactive glass
particles compared to pure silica ones is of high interest because it could prevent an undesirable burst
effect. Loading drug while soaking bioactive glass particles in simulated body fluid could also be a way
of slowing down drug release, thanks to the growth of a biological apatite layer onto their surface, as it
has been shown on microspheres with bovine serum albumin [37]. Functionalizing the particles with
amine groups, which have been shown to change particles surface charge from negative to positive [39],
could also be a way to increase drug loading if the drugs involved are negatively charged.
If injected in the blood stream, the nanometric size of the drug carriers is of tremendous
importance, as it determines their circulation half-life and cell uptake. Half-life is an important
parameter, especially for particles not functionalized to target a specific marker, as it allows them to
accumulate in the lesion before being cleared out of the body by the kidneys or the spleen. Particles
specific accumulation into tumor tissues is called the Enhanced Permeability and Retention (EPR)
effect, and lays on the presence of openings of 100–800 nm in tumor vasculature [40]. Smaller particles,
diffuse in tumor tissue, can thus have some retention thanks to the high interstitial pressure inside
the tumor, and possibly undergo cell uptake before being cleared by the mononuclear phagocyte
system. However, particles should neither be too small, as under about 50 nm they pass through
the vascular endothelium and are distributed in all over the body, non-specifically, and also because
their dispersion will be more difficult, having a higher surface charge; neither will particles that are
too big, as hydrodynamic stability will not be obtained in the blood stream. Hence, monodispersed
particles with sizes between 50 and 200 nm should be used. It is important to say that bioactive glass
nanoparticles can be internalized by human bone marrow and adipose-derived stem cells without
significantly inhibiting their metabolic activities [14]. It thus shows that drug delivery could be
achieved to help with bone tumor destruction and bone reconstruction.
Passive targeting will only be efficient for large tumors or lesion showing strong angiogenesis.
For metastatic lesions or if drug delivery is undergone with another aim than destroying cancerous
cells, active targeting through molecular recognition will be necessary. Composite nanoparticles with a
stimuli-responsive polymer containing the drug could also be a possibility if the stimuli can be applied
locally [41]. Another strategy could be a different injection system, with a direct implantation of the
particles in the desired tissues. For example, Couto et al. have developed a really promising bioactive
and biodegradable chitosan-based injectable system containing bioactive glass nanoparticles [42].
With a 50–100 nm sized nanoparticle quantity of 50%, the hydrogel has a gelation point of 36.8 ˝C,
adequate for intracorporal injection. Also, the nanometric size of the particles allows the hydrogel
to pass through small-gauge needles into bone defects. The bioactivity of this composite has been
confirmed with the growth of a hydroxyapatite layer after three days in simulated body fluid. A
thermo-responsive injectable system, with chitosan, bioactive glass nanoparticles and collagen has
also been obtained by another group [43], and another one synthesized an injectable system in the
form of 1.2 mm-diameter spheres, made of chitosan and bioactive glass nanoparticles crosslinked with
genipin [44].
Because of the mechanism of bioactive glass dissolution and biological apatite growth, not only
drugs but ions can be released. This process has some advantages like a local increase in pH due to the
surface reactions involved, which was shown to have an efficient anti-bacterial effect against some oral
bacteria [45]. However, more importantly, with the scope of ionic release and thanks to the versatility of
sol-gel chemistry, glasses doped with metal ions are now produced with the aim of triggering specific
biological responses. As extensively reported in a previous review, increased osteogenesis (Zn, Mg, Sr,
Li and B ions), angiogenesis (Co and Cu ions), antibacterial (Cu and Ag ions) and anti-inflammatory
(Zn and Sr ions) effects can be obtained [46]. Bioactive glass nanoparticles also have been successfully
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synthesized with Ag [21,22], or Zn [47] ions as dopants. El-Kady et al. performed a fine study of silver
release rates for samples containing 1% to 10% mol of dopant [21]. They found out that the extraction
of silver ions from the glasses followed a diffusion-controlled mechanism with release rates from
0.49 to 0.28 mg/L¨h´1, respectively. The smaller quantity of Ag+ released for glasses containing higher
amounts of dopant has been explained by a modification of the network connectivity, the replacement
of Ca2+ by Ag+ reducing the number of non-bridging oxygen groups, thus decreasing glass dissolution
rate. It is also worth noting that nanoparticles doped with rare earth ions presenting luminescent
properties, which could thus be used to monitor intracellular processes, have been synthesized by
some groups [15,29].
3.2. Polymer-Nanoparticles Composite Scaffolds
Bioactive glasses have been shown to be osteo-inductive, their dissolution products enhancing
osteoblasts differentiation, upregulating the expression of genes playing a role in osteoblasts
metabolism, proliferation and adhesion [48–52]. Bioactive glasses nanoparticles are thus highly
attractive for bone tissue repair and regeneration. This is all the more attractive given that a recent
study showed a better promotion of in vitro osteoblast-like cells and an earlier and increased expression
of some osteogenic marker genes for submicron compared to micron-sized particles [5]. However, if
nanoparticles can be directly injected in small bone defects, they cannot be used this way if the aim is to
repair large bone defects, as the hydroxyapatite structure obtained will not be porous enough to permit
the migration and proliferation of osteoblasts and mesenchymal cells and a good vascularization of
the newly formed bone. Biomimetic structures are thus necessary for an optimal osteo-integration. In
this scope, highly porous bioactive glass monoliths have been synthesized. Another way to obtain
such macroporous structures is to disperse bioactive glass nanoparticles in a polymer matrix with
an appropriate shape, in short, synthesizing macroporous composite scaffolds. The aim of adding
nanoparticles into the polymeric structure is thus both to increase their mechanical properties that
are intrinsically quite poor and provide a good bioactivity and osteo-induction while maintaining the
polymer properties, such as flexibility.
Different methods have been used to produce non-cytotoxic polymer-bioactive glass particles
composites, but some like melt blending and thermal injection molding [53], twin-screw
extrusion [54,55] or solvent casting [6], do not permit macroporous structures to be ontained. However,
phase separation [56], lyophilization [57] and thermally-induced phase separation (TIPS), [20,58–63]
(a variation of freeze-drying) processes have shown to allow the formation of interconnected pore
structures with pore sizes from 10 to 300 µm. Considering the TIPS process, composite morphology
depends mainly on the polymer used, as presented in Figure 3. In the TIPS process, bioactive particles
are first mixed with a polymer and a decrease in temperature induced a separation into two phases.
The solvent-rich phase is then removed by extrusion or sublimation, giving rise to open pores, while
the composite-rich phase solidifies, creating the macroporous scaffold. The polymers used can be
natural, like chitin [57]; chitosan-gelatin [58]; gelatin [59]; collagen-phosphatidylserine [62] or synthetic
like poly(L-lactic acid) [20,56,63,64]; poly(lactide-co-glycolide) [60,61] or poly(D,L-lactide) [60]. All
these studies have shown an increase in mechanical properties along with the addition of bioactive
glass particles and their quantity inside the composite. However, the compressive strength and
modulus measured are low compared to those of natural bones. The size of bioactive glass particles has
been shown to have a strong impact on the mechanical properties of nanoparticle-gelatin composite
scaffolds [59]. For example, for composites with a particles-polymer weight ratio of 50:50, adding
14 nm particles led to an increase in yield strength from 1.8 to 15.4 MPa. Increasing the size of
the particles to 65, 106, 580 and 946 nm induced a decrease of yield strength to 10.9, 10.5, 2.1 and
0.8 MPa, respectively. It is worth noticing that, in this study, mechanical properties similar to cancellous
bones have been obtained. The authors attributed these good mechanical properties to a homogeneous
dispersion of the particles inside the polymer and to strong interactions between particles and gelatin,
thanks to the presence of surface silanol groups, still present at the particles surface because of the
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absence of high temperature processing. Other studies have shown the impact of particles-polymer
covalent bonding on the composites mechanical properties while functionalizing the nanoparticles
with low molecular-weight poly(L-lactide) through diisocyanate coupling [64] or 3-aminopropyl
trimethoxysilane [56]. As previously mentioned, not only particle-polymer interactions matters but
also particles dispersion into the matrix. Liu et al. [64] showed that while increasing the bioactive
particles loading in poly(L-lactide), the composite tensile strength decreased due to a severe aggregation
of the particles.
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Figure 3. SEM micrographs of bioactive glass particles-polymer composites made by thermally-induced
phase separation (TIPS), with poly(L-lactide), [20] (a) and [63] (b); poly(lactide-co-glycolide), [61] (c);
chitosan-gelatin, [58] (d); gelatin, [59] (e) and collagen-phosphatidyserine, [62] (f) as polymer matrix.
Figure adapted with permission from [20,58,61–63] ©Elsevier, [59] ©American chemical Society.
Apart from enhancing mechanical compressive strength, the use of bioactive glass nanoparticles
to obtain bioactive composite also induces improved bioactive properties. This can be explained by a
morphology mimicking the nanoscale features of natural bones, which has been proven to increase
osteoblast adhesion and proliferation [65]. Of course, this argument is valid only if nanoparticles
are present on the polymer surface, with a direct contact with body fluids, thus emphasizing again
the importance of homogeneous particles dispersion inside the polymer, related to the synthesis of
non-agglomerated objects. A second reason is the enhanced bioactivity of particles with nanometric
sizes compared to micrometric ones, which will be progressively exposed to body fluids while the
polymer degrades. Ideally, a congruent dissolution of both polymer and bioactive glass nanoparticles
should occur in order to obtain a biological hydroxyapatite scaffold with a similar morphology to the
one of the composite. Also an equivalent degradation of particles and polymer should maintain the
mechanical properties as new bone grows. The use of bioactive glasses is again highly interesting
as their dissolution products increase locally body fluids pH. It can thus counter the decrease in pH
induced by synthetic polymers hydrolysis [60,61]. It is also worth mentioning that the bioactive glass
nanoparticles used to form the composites can be loaded with drugs or doped with metal ions to add
the benefits of local antibacterial, anti-tumoral or pro-angiogenesis drugs/ions release to hard tissue
regeneration and repair.
The biomedical applications of such bioactive glass nanoparticles-polymer composites are
mainly for hard tissue engineering, in orthopedics or dentistry (periodontal bone regeneration).
But applications for soft tissue repair have also been proposed [66]. One example, which is well
described in the latter review, is the development of composites for heart patches which could provide
mechanical support to the heart and help tissue repair after damages linked to the blockage of the
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coronary arteries irrigating the heart. With this scope, Chen et al. have created bioactive glass
nanoparticle—poly(glycerol sebacate) composites with good mechanical properties, flexibility and
biocompatibility [67]. Composites also have shown good results for wound dressing. For example
Rai et al. have synthesized bioactive glass nanoparticles-poly(3-hydroxyoctanoate) composite films
which have shown to decrease blood clotting time [68]. In addition to hemostatic properties, composite
films can help with soft tissue repair, as demonstrated by Day et al. with polyglycolic acid meshes
coated with bioactive glass micron-sized particles subcutaneously implanted in rats [69]. After
42 days, they presented complete tissue infiltration and neovascularization. Also, bioactive glass
nanoparticle–gelatin composite conduits have be shown to be good candidates to help peripheral
nerve regeneration [70]. Considering the poor regenerative capabilities of adult lung tissue, bioactive
glass particle-polymer composites have been considered for lung tissue engineering, as it could provide
a support for lung cells proliferation and adhesion. A poly(D,L-lactic acid) porous foam loaded with 5%
bioactive glass micron-sized particles, for example, has been shown to be a promising candidate [71].
3.3. Implants Coating
Even though bioactive scaffolds with good mechanical properties have been produced, their use
for load-bearing application is still a challenge. In order to protect against corrosion and solve the
problem of bonding with tissues, the idea of coating metallic implants with bioactive glass has emerged.
The electrophoretic deposition (EPD) technique involves the use of bioactive glass nanoparticles.
This technique has the advantage of creating conformal coatings of single- or multi-phase particles
onto a conductive substrate. Using EPD, bioactive glass microparticles dispersed in water have
been deposited, the most uniform coatings resulting from electrodeposition in neutral solutions [72].
Another group has shown the feasibility of co-depositing carbon nanotubes and bioactive glass
particles in order to create nanostructured composite coatings [73]. Additionally, adhesive several
micrometer thick composite coatings made of bioactive glass particles dispersed in chitosan or alginate
have been produced by EPD [74]. Very recently, Rego et al. realized bioactive coatings with an
architecture similar to nacre using bioactive glass nanoparticles, chitosan and hyaluronic acid modified
with catechol groups through layer-by-layer deposition [75]. These coatings have shown excellent
adhesive properties and good bioactivity, and could thus be used as coating for implants in dentistry
or orthopedics.
In addition to metallic implants, coatings using bioactive glass nanoparticles have been performed
onto ceramic scaffolds. Not only an increased bioactivity, but also enhanced mechanical properties
have been obtained. For example, a 14-fold increase in compressive strength and a 3-fold increase in
compressive modulus have been achieved by coating hydroxyapatite/β-tricalcium phosphate scaffolds
with a composite of 40 nm sized bioactive glass particles in polycaprolactone (30 wt%) [76]. A 6.5-fold
increase in compressive strength (from 0.22 to 1.49 MPa) has also been achieved by coating a piece
of cleaned cancellous bone extracted from an adult bovine femur with bioactive glass nanoparticles
dispersed in polyvinyl alcohol [77]. In both cases, the macro-porous structure of the scaffold has been
unaltered by the coating process.
3.4. Dispersed Nanoparticles for Dentistry and Wound Healing
Bioactive glass particles have also found applications as dispersion into a body fluid like blood or
saliva, or in paste like Vaseline. Exploring new fields of applications, it has been found that bioactive
glass particles present good hemostatic properties, i.e., while mixed with blood, they decrease its
clotting time and increase its coagulation rate. This could be explained by the release of Ca2+ ions,
which play a role in fibrin polymerization and clot stabilization [78]. Quickly mixed with blood, they
could thus prevent large blood loss. Their positive impact onto wound healing also has been shown
by applying micron sized bioactive glass particles into open wounds before sewing them: with no
increase in inflammatory reaction compared to control wounds, newly formed subcutaneous tissues
presented higher breaking strength [79]. Studies have also shown the impact of bioactive glass particles
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design. For example, nanoporous microparticles induced lower clotting times than dense ones [80],
which could be explained by blood capillary adsorption inside the pores of the particles. The particles
synthesis process has also been shown to have a huge impact on wound healing: sol-gel-derived
particles dispersed in Vaseline and used as an ointment onto full-thickness skin wounds led to a faster
healing than melt-derived particles [81]. As for hard tissues regeneration, a larger specific surface area
is thus beneficial. However, micron-sized particles presenting a nano-structuration and well-separated
30 nm-sized particles both made using sol-gel chemistry had the same wound healing efficiency, which
can be easily understood: as with blood thickening, particles should quickly aggregate, only retaining
a global nano-structuration.
Thanks to their antibacterial and hard tissue regeneration properties, bioactive glass nanoparticles
are promising materials for applications in dentistry. As mentioned before, bioactive glass dissolution
leads to an increase in pH providing good antibacterial properties [82]. Waltimo et al. showed
the advantage of using bioactive glass nanoparticles for teeth root canal disinfection through
a drastic increase in killing efficacy of E. faecalis using 30 nm-sized compared to 100 µm-sized
particles [83]. Concerning hard tissue regeneration, bioactive glass particles have been studied for
dentine remineralization and dentine repair to solve hypersensitivity problems. Again, a particle size
in the nanometric range is highly beneficial. Vollenweider et al. showed that 30–50 nm-sized particles
(170 mg/mL, dispersed in water) induced a faster remineralization of Ethylenediaminetetraacetic acid
(EDTA)-demineralized teeth compared with ~100 µm-sized particles [84]. As for the antibacterial effect,
the better efficiency of nanometric bioactive glass particles arises from an increase in specific surface
area and thus an increase in dissolution rate. The use of nanoparticles has also been shown to be
promising for hypersensitivity treatment as nanoparticles are able to penetrate dentine exposed tubules
rather than just remaining onto dentine surface [85]. For this study, particles were dispersed in saliva
and the slurry was mechanically brushed onto the teeth for 2 min. Then the teeth were rinsed and
stored in saliva for 24 h at 36 ˝C. Using nanoparticles, rods of apatite grew from the exposed tubules,
obstructing them, whereas microparticles led to a surface apatite layer onto the teeth. Bioactive glass
nanoparticles are thus very promising to provide a longer-term solution to hypersensitivity problems,
as apatite rods would be more difficult to dislodge through brushing and normal eating processes.
4. Conclusions
With an increasingly better comprehension of sol-gel processes, it is now possible to synthesize
bioactive glass nanoparticles with a desired size. Some progress is, however, still necessary in order
to control their dispersity in size and to prevent their agglomeration. Tailored porosity can also be
obtained while playing onto surfactant nature, concentration and synthesis protocol.
A broad range of bioactive glass nanoparticles-based materials have been presented in this review,
focusing on their biomedical advantages compared to bulk or micro-sized-based materials. Most of
their advantages lie in their superior specific surface area, leading to higher dissolution rate and thus
faster apatite formation and ions/drugs release. Dispersed inside a polymeric scaffold, they have
been shown to increase the mechanical properties of such composite, which are now reaching those of
natural bones, and to provide biomimetic nano-structuration enhancing cell adhesion.
Although some work still needs to be done in order to design materials perfectly matching
biomedical purposes, most of the materials presented have shown good biocompatibility and no
cytotoxicity, paving the way for in vivo tests.
Acknowledgments: Jean-Marie Nedelec would like to thank the Guest Editor of this Special Issue,
Gigliola Lusvardi for her invitation to contribute.
Author Contributions: Charlotte Vichery and Jean-Marie Nedelec equally contributed to the writing and
correction of this review paper.
Conflicts of Interest: The authors declare no conflict of interest.
Materials 2016, 9, 288 14 of 17
References
1. Jones, J.R. Review of bioactive glass: From Hench to hybrids. Acta Biomater. 2013, 9, 4457–4486. [CrossRef]
[PubMed]
2. González, P.; Serra, J.; Liste, S.; Chiussi, S.; León, B.; Pérez-Amor, M. Raman spectroscopic study of bioactive
silica based glasses. J. Non Cryst. Solids 2003, 320, 92–99. [CrossRef]
3. Hench, L.L. Bioceramics: From concept to clinic. J. Am. Ceram. Soc. 1991, 74, 1487–1510. [CrossRef]
4. Gunawidjaja, P.N.; Lo, A.Y.H.; Izquierdo-Barba, I.; García, A.; Arcos, D.; Stevensson, B.; Grins, J.;
Vallet-Regí, M.; Edén, M. Biomimetic apatite mineralization mechanisms of mesoporous bioactive glasses as
probed by multinuclear 31P, 29Si, 23Na and 13C solid-state NMR. J. Phys. Chem. C 2010, 114, 19345–19356.
[CrossRef]
5. Liu, S.; Gong, W.; Dong, Y.; Hu, Q.; Chen, X.; Gao, X. The effect of submicron bioactive glass particles on
in vitro osteogenesis. RSC Adv. 2015, 5, 38830–38836. [CrossRef]
6. Misra, S.K.; Mohn, D.; Brunner, T.J.; Stark, W.J.; Philip, S.E.; Roy, I.; Salih, V.; Knowles, J.C.; Boccaccini, A.R.
Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass® composites.
Biomaterials 2008, 29, 1750–1761. [CrossRef] [PubMed]
7. Hench, L.L. The story of Bioglass®. J. Mater. Sci. Mater. Med. 2006, 17, 967–978. [CrossRef] [PubMed]
8. Brunner, T.J.; Grass, R.N.; Stark, W.J. Glass and bioglass nanopowders by flame synthesis. Chem. Commun.
2006. [CrossRef] [PubMed]
9. Stöber, W.; Fink, A.; Bohn, E. Controlled growth of monodisperse silica spheres in the micron size range.
J. Colloid Interface Sci. 1968, 26, 62–69. [CrossRef]
10. Lin, S.; Ionescu, C.; Pike, K.J.; Smith, M.E.; Jones, J.R. Nanostructure evolution and calcium distribution in
sol-gel derived bioactive glass. J. Mater. Chem. 2009, 19, 1276–1282. [CrossRef]
11. Sepulveda, P.; Jones, J.R.; Hench, L.L. Characterization of melt-derived 45S5 and sol-gel-derived 58S bioactive
glasses. J. Biomed. Mater. Res. 2001, 58, 734–740. [CrossRef] [PubMed]
12. Hench, L.L.; West, J.K. The sol-gel process. Chem. Rev. 1990, 90, 33–72. [CrossRef]
13. Chen, X.; Guo, C.; Zhao, N. Preparation and characterization of the sol-gel nano-bioactive glasses modified
by the coupling agent gamma-aminopropyltriethoxysilane. Appl. Surf. Sci. 2008, 255, 466–468. [CrossRef]
14. Tsigkou, O.; Labbaf, S.; Stevens, M.M.; Porter, A.E.; Jones, J.R. Monodispersed bioactive glass submicron
particles and their effect on bone marrow and adipose tissue-derived stem cells. Adv. Healthc. Mater. 2014, 3,
115–125. [CrossRef] [PubMed]
15. Lukowiak, A.; Lao, J.; Lacroix, J.; Nedelec, J.-M. Bioactive glass nanoparticles obtained through sol-gel
chemistry. Chem. Commun. 2013, 49, 6620–6622. [CrossRef] [PubMed]
16. Hong, Z.; Luz, G.M.; Hampel, P.J.; Jin, M.; Liu, A.; Chen, X.; Mano, J.F. Mono-dispersed bioactive glass
nanospheres: Preparation and effects on biomechanics of mammalian cells. J. Biomed. Mater. Res. 2010, 95A,
747–754. [CrossRef] [PubMed]
17. Ajita, J.; Saravanan, S.; Selvamurugan, N. Effect of size of bioactive glass nanoparticles on mesenchymal stem
cell proliferation for dental and orthopedic applications. Mater. Sci. Eng. C 2015, 53, 142–149. [CrossRef]
[PubMed]
18. Fan, J.P.; Kalia, P.; Di Silvio, L.; Huang, J. In vitro response of human osteoblasts to multi-step sol-gel derived
bioactive glass nanoparticles for bone tissue engineering. Mater. Sci. Eng. C 2014, 36, 206–214. [CrossRef]
[PubMed]
19. Luz, G.M.; Mano, J.F. Nanoengineering of bioactive glasses: Hollow and dense nanospheres. J. Nanopart. Res.
2013, 15, 1–11. [CrossRef]
20. El-Kady, A.M.; Ali, A.F.; Farag, M.M. Development, characterization, and in vitro bioactivity studies of sol-gel
bioactive glass/poly(L-lactide) nanocomposite scaffolds. Mater. Sci. Eng. C 2010, 30, 120–131. [CrossRef]
21. El-Kady, A.M.; Ali, A.F.; Rizk, R.A.; Ahmed, M.M. Synthesis, characterization and microbiological response
of silver doped bioactive glass nanoparticles. Ceram. Int. 2012, 38, 177–188. [CrossRef]
22. Delben, J.R.J.; Pimentel, O.M.; Coelho, M.B.; Candelorio, P.D.; Furini, L.N.; dos Santos, F.A.; de Vicente, F.S.;
Delben, A.A.S.T. Synthesis and thermal properties of nanoparticles of bioactive glasses containing silver.
J. Therm. Anal. Calorim. 2009, 97, 433–436. [CrossRef]
23. Xia, W.; Chang, J. Preparation and characterization of nano-bioactive-glasses (NBG) by a quick
alkali-mediated sol-gel method. Mater. Lett. 2007, 61, 3251–3253. [CrossRef]
Materials 2016, 9, 288 15 of 17
24. Yun, H.; Kim, S.; Lee, S.; Song, I. Synthesis of high surface area mesoporous bioactive glass nanospheres.
Mater. Lett. 2010, 64, 1850–1853. [CrossRef]
25. Yu, B.; Turdean-Ionescu, C.A.; Martin, R.A.; Newport, R.J.; Hanna, J.V.; Smith, M.E.; Jones, J.R. Effect
of calcium source on structure and properties of sol-gel derived bioactive glasses. Langmuir 2012, 28,
17465–17476. [CrossRef] [PubMed]
26. Sun, Y.-S.; Li, A.-L.; Xu, F.-J.; Qiu, D. A low-temperature sol-gel route for the synthesis of bioactive calcium
silicates. Chin. Chem. Lett. 2013, 24, 170–172. [CrossRef]
27. Doostmohammadi, A.; Monshi, A.; Salehi, R.; Fathi, M.H.; Golniya, Z.; Daniels, A.U. Bioactive glass
nanoparticles with negative zeta potential. Ceram. Int. 2011, 37, 2311–2316. [CrossRef]
28. Labbaf, S.; Tsigkou, O.; Müller, K.H.; Stevens, M.M.; Porter, A.E.; Jones, J.R. Spherical bioactive glass
particles and their interaction with human mesenchymal stem cells in vitro. Biomaterials 2011, 32, 1010–1018.
[CrossRef] [PubMed]
29. Xue, Y.; Du, Y.; Yan, J.; Liu, Z.; Ma, P.X.; Chen, X.; Lei, B. Monodisperse photoluminescent and highly
biocompatible bioactive glass nanoparticles for controlled drug delivery and cell imaging. J. Mater. Chem. B
2015, 3, 3831–3839. [CrossRef]
30. Li, Y.; Chen, X.; Ning, C.; Yuan, B.; Hu, Q. Facile synthesis of mesoporous bioactive glasses with controlled
shapes. Mater. Lett. 2015, 161, 605–608. [CrossRef]
31. Hu, Q.; Li, Y.; Zhao, N.; Ning, C.; Chen, X. Facile synthesis of hollow mesoporous bioactive glass sub-micron
spheres with a tunable cavity size. Mater. Lett. 2014, 134, 130–133. [CrossRef]
32. Li, Y.; Bastakoti, B.P.; Yamauchi, Y. Smart soft-templating synthesis of hollow mesoporous bioactive glass
spheres. Chem. Eur. J. 2015, 21, 8038–8042. [CrossRef] [PubMed]
33. Liang, Q.; Hu, Q.; Miao, G.; Yuan, B.; Chen, X. A facile synthesis of novel mesoporous bioactive glass
nanoparticles with various morphologies and tunable mesostructure by sacrificial liquid template method.
Mater. Lett. 2015, 148, 45–49. [CrossRef]
34. Yan, X.; Yu, C.; Zhou, X.; Tang, J.; Zhao, D. Highly ordered mesoporous bioactive glasses with superior
in vitro bone-forming bioactivities. Angew. Chem. Int. Ed. 2004, 43, 5980–5984. [CrossRef] [PubMed]
35. Wu, C.; Chang, J. Mesoporous bioactive glasses: Structure characteristics, drug/growth factor delivery and
bone regeneration application. Interface Focus 2012, 2, 292–306. [CrossRef] [PubMed]
36. Arcos, D.; López-Noriega, A.; Ruiz-Hernández, E.; Terasaki, O.; Vallet-Regí, M. Ordered mesoporous
microspheres for bone grafting and drug delivery. Chem. Mater. 2009, 21, 1000–1009. [CrossRef]
37. Wu, C.; Zhang, Y.; Ke, X.; Xie, Y.; Zhu, H.; Crawford, R.; Xiao, Y. Bioactive mesopore-glass microspheres with
controllable protein-delivery properties by biomimetic surface modification. J. Biomed. Mater. Res. 2010, 95A,
476–485. [CrossRef] [PubMed]
38. Zhao, L.; Yan, X.; Zhou, X.; Zhou, L.; Wang, H.; Tang, J.; Yu, C. Mesoporous bioactive glasses for controlled
drug release. Microporous Mesoporous Mater. 2008, 109, 210–215. [CrossRef]
39. El-Fiqi, A.; Kim, J.-H.; Kim, H.-W. Osteoinductive fibrous scaffolds of biopolymer/mesoporous bioactive
glass nanocarriers with excellent bioactivity and long-term delivery of osteogenic drug. ACS Appl. Mater.
Interfaces 2015, 7, 1140–1152. [CrossRef] [PubMed]
40. Sun, T.; Zhang, Y.S.; Pang, B.; Hyun, D.C.; Yang, M.; Xia, Y. Engineered nanoparticles for drug delivery in
cancer therapy. Angew. Chem. Int. Ed. 2014, 53, 12320–12364. [CrossRef] [PubMed]
41. Arcos, D.; Vallet-Regí, M. Bioceramics for drug delivery. Acta Mater. 2013, 61, 890–911. [CrossRef]
42. Couto, D.S.; Hong, Z.; Mano, J.F. Development of bioactive and biodegradable chitosan-based injectable
systems containing bioactive glass nanoparticles. Acta Biomater. 2009, 5, 115–123. [CrossRef] [PubMed]
43. Moreira, C.D.F.; Carvalho, S.M.; Mansur, H.S.; Pereira, M.M. Thermogelling chitosan-collagen-bioactive
glass nanoparticle hybrids as potential injectable systems for tissue engineering. Mater. Sci. Eng. C 2016, 58,
1207–1216. [CrossRef] [PubMed]
44. Leite, Á.J.; Caridade, S.G.; Mano, J.F. Synthesis and characterization of bioactive biodegradable chitosan
composite spheres with shape memory capability. J. Non Cryst. Solids 2016, 432, 158–166. [CrossRef]
45. Allan, I.; Newman, H.; Wilson, M. Antibacterial activity of particulate Bioglass® against supra- and
subgingival bacteria. Biomaterials 2001, 22, 1683–1687. [CrossRef]
46. Hoppe, A.; Güldal, N.S.; Boccaccini, A.R. A review of the biological response to ionic dissolution products
from bioactive glasses and glass-ceramics. Biomaterials 2011, 32, 2757–2774. [CrossRef] [PubMed]
Materials 2016, 9, 288 16 of 17
47. Goh, Y.-F.; Alshemary, A.Z.; Akram, M.; Abdul Kadir, M.R.; Hussain, R. In vitro study of nano-sized zinc
doped bioactive glass. Mater. Chem. Phys. 2013, 137, 1031–1038. [CrossRef]
48. Xynos, I.D.; Edgar, A.J.; Buttery, L.D.K.; Hench, L.L.; Polak, J.M. Gene-expression profiling of human
osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution. J. Biomed. Mater. Res.
2001, 55, 151–157. [CrossRef]
49. Effah Kaufmann, E.A.B.; Ducheyne, P.; Shapiro, I.M. Evaluation of osteoblast response to porous bioactive
glass (45S5) substrates by RT-PCR analysis. Tissue Eng. 2000, 6, 19–28. [CrossRef] [PubMed]
50. Jell, G.; Notingher, I.; Tsigkou, O.; Notingher, P.; Polak, J.M.; Hench, L.L.; Stevens, M.M. Bioactive
glass-induced osteoblast differentiation: A noninvasive spectroscopic study. J. Biomed. Mater. Res. 2008, 86A,
31–40. [CrossRef] [PubMed]
51. Bielby, R.C.; Christodoulou, I.S.; Pryce, R.S.; Radford, W.J.P.; Hench, L.L.; Polak, J.M. Time- and
concentration-dependent effects of dissolution products of 58S sol-gel bioactive glass on proliferation
and differentiation of murine and human osteoblasts. Tissue Eng. 2004, 10, 1018–1026. [CrossRef] [PubMed]
52. Christodoulou, I.; Buttery, L.D.K.; Tai, G.; Hench, L.L.; Polak, J.M. Characterization of human fetal osteoblasts
by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products.
J. Biomed. Mater. Res. 2006, 77B, 431–446. [CrossRef] [PubMed]
53. Ji, L.; Wang, W.; Jin, D.; Zhou, S.; Song, X. In vitro bioactivity and mechanical properties of bioactive glass
nanoparticles/polycaprolactone composites. Mater. Sci. Eng. C 2015, 46, 1–9. [CrossRef] [PubMed]
54. Leonor, I.B.; Sousa, R.A.; Cunha, A.M.; Reis, R.L.; Zhong, Z.P.; Greenspan, D. Novel starch
thermoplastic/bioglass composites: Mechanical properties, degradation behavior and in vitro bioactivity.
J. Mater. Sci. Mater. Med. 2002, 13, 939–945. [CrossRef] [PubMed]
55. Niemelä, T.; Niiranen, H.; Kellomäki, M.; Törmälä, P. Self-reinforced composites of bioabsorbable polymer
and bioactive glass with different bioactive glass contents. Part I: Initial mechanical properties and bioactivity.
Acta Biomater. 2005, 1, 235–242. [CrossRef] [PubMed]
56. Zhang, K.; Wang, Y.; Hillmyer, M.A.; Francis, L.F. Processing and properties of porous
poly(L-lactide)/bioactive glass composites. Biomaterials 2004, 25, 2489–2500. [CrossRef] [PubMed]
57. Sowmya, S.; Kumar, P.T.S.; Chennazhi, K.P.; Nair, S.V.; Tamura, H.; Rangasamy, J. Biocompatible β-chitin
hydrogel/nanobioactive glass ceramic nanocomposite scaffolds for periodontal bone regeneration. Trends
Biomater. Artif. Organs 2011, 25, 1–11.
58. Peter, M.; Binulal, N.S.; Nair, S.V.; Selvamurugan, N.; Tamura, H.; Jayakumar, R. Novel biodegradable
chitosan-gelatin/nano-bioactive glass ceramic composite scaffolds for alveolar bone tissue engineering.
Chem. Eng. J. 2010, 158, 353–361. [CrossRef]
59. Wang, C.; Shen, H.; Tian, Y.; Xie, Y.; Li, A.; Ji, L.; Niu, Z.; Wu, D.; Qiu, D. Bioactive nanoparticle-gelatin
composite scaffold with mechanical performance comparable to cancellous bones. ACS Appl. Mater. Interfaces
2014, 6, 13061–13068. [CrossRef] [PubMed]
60. Maquet, V.; Boccaccini, A.R.; Pravata, L.; Notingher, I.; Jérôme, R. Porous poly(α-hydroxyacid)/Bioglass®
composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation. Biomaterials
2004, 25, 4185–4194. [CrossRef] [PubMed]
61. Boccaccini, A.R.; Maquet, V. Bioresorbable and bioactive polymer/Bioglass® composites with tailored pore
structure for tissue engineering applications. Compos. Sci. Technol. 2003, 63, 2417–2429. [CrossRef]
62. Xu, C.; Su, P.; Chen, X.; Meng, Y.; Yu, W.; Xiang, A.P.; Wang, Y. Biocompatibility and osteogenesis
of biomimetic bioglass-collagen-phosphatidylserine composite scaffolds for bone tissue engineering.
Biomaterials 2011, 32, 1051–1058. [CrossRef] [PubMed]
63. Hong, Z.; Reis, R.L.; Mano, J.F. Preparation and in vitro characterization of scaffolds of poly(L-lactic acid)
containing bioactive glass ceramic nanoparticles. Acta Biomater. 2008, 4, 1297–1306. [CrossRef] [PubMed]
64. Liu, A.; Hong, Z.; Zhuang, X.; Chen, X.; Cui, Y.; Liu, Y.; Jing, X. Surface modification of bioactive glass
nanoparticles and the mechanical and biological properties of poly(L-lactide) composites. Acta Biomater.
2008, 4, 1005–1015. [CrossRef] [PubMed]
65. Palin, E.; Liu, H.; Webster, T.J. Mimicking the nanofeatures of bone increases bone-forming cell adhesion and
proliferation. Nanotechnology 2005, 16, 1828. [CrossRef]
66. Miguez-Pacheco, V.; Hench, L.L.; Boccaccini, A.R. Bioactive glasses beyond bone and teeth: Emerging
applications in contact with soft tissues. Acta Biomater. 2015, 13, 1–15. [CrossRef] [PubMed]
Materials 2016, 9, 288 17 of 17
67. Chen, Q.; Jin, L.; Cook, W.D.; Mohn, D.; Lagerqvist, E.L.; Elliott, D.A.; Haynes, J.M.; Boyd, N.; Stark, W.J.;
Pouton, C.W.; et al. Elastomeric nanocomposites as cell delivery vehicles and cardiac support devices. Soft
Matter 2010, 6, 4715–4726. [CrossRef]
68. Rai, R.; Boccaccini, A.R.; Knowles, J.C.; Locke, I.C.; Gordge, M.P.; McCormick, A.; Salih, V.; Mordon, N.;
Keshavarz, T.; Roy, I. Fabrication of a novel poly(3-hydroxyoctanoate)/nanoscale bioactive glass composite
film with potential as a multifunctional wound dressing. In AIP Conference Proceedings; AIP Publishing:
Melville, NY, USA, 2010; Volume 1255, pp. 126–128.
69. Day, R.M.; Boccaccini, A.R.; Shurey, S.; Roether, J.A.; Forbes, A.; Hench, L.L.; Gabe, S.M. Assessment
of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials 2004, 25,
5857–5866. [CrossRef] [PubMed]
70. Koudehi, M.F.; Fooladi, A.A.I.; Mansoori, K.; Jamalpoor, Z.; Amiri, A.; Nourani, M.R. Preparation and
evaluation of novel nano-bioglass/gelatin conduit for peripheral nerve regeneration. J. Mater. Sci. Mater.
Med. 2013, 25, 363–373. [CrossRef] [PubMed]
71. Verrier, S.; Blaker, J.J.; Maquet, V.; Hench, L.L.; Boccaccini, A.R. PDLLA/Bioglass® composites for soft-tissue
and hard-tissue engineering: An in vitro cell biology assessment. Biomaterials 2004, 25, 3013–3021. [CrossRef]
[PubMed]
72. Pishbin, F.; Simchi, A.; Ryan, M.P.; Boccaccini, A.R. A study of the electrophoretic deposition of Bioglass®
suspensions using the Taguchi experimental design approach. J. Eur. Ceram. Soc. 2010, 30, 2963–2970.
[CrossRef]
73. Charlotte Schausten, M.; Meng, D.; Telle, R.; Boccaccini, A.R. Electrophoretic deposition of carbon nanotubes
and bioactive glass particles for bioactive composite coatings. Ceram. Int. 2010, 36, 307–312. [CrossRef]
74. Zhitomirsky, D.; Roether, J.A.; Boccaccini, A.R.; Zhitomirsky, I. Electrophoretic deposition of bioactive
glass/polymer composite coatings with and without HA nanoparticle inclusions for biomedical applications.
J. Mater. Process. Technol. 2009, 209, 1853–1860. [CrossRef]
75. Rego, S.J.; Vale, A.C.; Luz, G.M.; Mano, J.F.; Alves, N.M. Adhesive bioactive coatings inspired by sea life.
Langmuir 2016, 32, 560–568. [CrossRef] [PubMed]
76. Roohani-Esfahani, S.I.; Nouri-Khorasani, S.; Lu, Z.F.; Appleyard, R.C.; Zreiqat, H. Effects of bioactive glass
nanoparticles on the mechanical and biological behavior of composite coated scaffolds. Acta Biomater. 2011,
7, 1307–1318. [CrossRef] [PubMed]
77. Esfahani, S.I.R.; Tavangarian, F.; Emadi, R. Nanostructured bioactive glass coating on porous hydroxyapatite
scaffold for strength enhancement. Mater. Lett. 2008, 62, 3428–3430. [CrossRef]
78. Ostomel, T.A.; Shi, Q.; Tsung, C.-K.; Liang, H.; Stucky, G.D. Spherical bioactive glass with enhanced rates of
hydroxyapatite deposition and hemostatic activity. Small 2006, 2, 1261–1265. [CrossRef]
79. Gillette, R.L.; Swaim, S.F.; Sartin, E.A.; Bradley, D.M.; Coolman, S.L. Effects of a bioactive glass on healing of
closed skin wounds in dogs. Am. J. Vet. Res. 2001, 62, 1149–1153. [CrossRef] [PubMed]
80. Hu, G.; Xiao, L.; Tong, P.; Bi, D.; Wang, H.; Ma, H.; Zhu, G.; Liu, H. Antibacterial hemostatic dressings with
nanoporous bioglass containing silver. Int. J. Nanomed. 2012, 7, 2613–2620. [CrossRef] [PubMed]
81. Lin, C.; Mao, C.; Zhang, J.; Li, Y.; Chen, X. Healing effect of bioactive glass ointment on full-thickness skin
wounds. Biomed. Mater. 2012, 7. [CrossRef] [PubMed]
82. Stoor, P.; Söderling, E.; Salonen, J.I. Antibacterial effects of a bioactive glass paste on oral microorganisms.
Acta Odontol. Scand. 1998, 56, 161–165. [CrossRef] [PubMed]
83. Waltimo, T.; Brunner, T.J.; Vollenweider, M.; Stark, W.J.; Zehnder, M. Antimicrobial effect of nanometric
bioactive glass 45S5. J. Dent. Res. 2007, 86, 754–757. [CrossRef] [PubMed]
84. Vollenweider, M.; Brunner, T.J.; Knecht, S.; Grass, R.N.; Zehnder, M.; Imfeld, T.; Stark, W.J. Remineralization
of human dentin using ultrafine bioactive glass particles. Acta Biomater. 2007, 3, 936–943. [CrossRef]
[PubMed]
85. Curtis, A.R.; West, N.X.; Su, B. Synthesis of nanobioglass and formation of apatite rods to occlude exposed
dentine tubules and eliminate hypersensitivity. Acta Biomater. 2010, 6, 3740–3746. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
